Literature DB >> 2731974

Ulcerative colitis: specific antibodies against a colonic epithelial Mr 40,000 protein.

K M Das1, S Sakamaki, M Vecchi.   

Abstract

A colon tissue-bound disease specific IgG (CCA-IgG) antibody can be eluted from the colonic tissue of patients with ulcerative colitis (UC). CCA-IgG recognizes an Mr 40,000 protein present in both normal and diseased colon. Using an anti-Mr 40,000 murine monoclonal antibody this protein has been localized exclusively in colonic epithelial cells mainly along the baso-lateral domains of plasma membrane. Non-colonic epithelial tissues from 12 different organs including small intestine did not react with the anti-Mr 40,000 monoclonal antibody. The Mr 40,000 protein is present in the RPMI-4788 colon cancer cells but not in HeLa. The antibody dependent cell-mediated cytolysis by UC sera against RPMI-4788 cells was inhibited by anti-Mr 40,000 polyclonal antibody. These findings suggest that CCA-IgG and the Mr 40,000 colonic epithelial protein are involved in an autoimmune reaction and may be important in the pathogenesis of UC.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2731974     DOI: 10.3109/08820138909112256

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  3 in total

1.  Serum and tissue autoantibodies to colonic epithelium in ulcerative colitis.

Authors:  K M Das
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

2.  Expression of the 40 kD protein in DLD-1 colon cancer cells and the effect of cytokines.

Authors:  K M Das; L Squillante; F Robertson
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

3.  Mr 40,000 human colonic epithelial protein expression in colonic mucosa and presence of circulating anti-Mr 40,000 antibodies in cotton top tamarins with spontaneous colitis.

Authors:  K M Das; M Vecchi; L Squillante; A Dasgupta; M Henke; N Clapp
Journal:  Gut       Date:  1992-01       Impact factor: 23.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.